Clinical Trials Browser

Breast Neoplasms, Hepatitis C

NCT02366286 2026-04-24

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

Completed

892 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

NCT01280825 2026-03-04

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Recruiting

1,200 enrolled

Autoimmune Diseases, Blood Coagulation Disorders, Heart Diseases, Hepatitis C, Inflammatory Bowel Diseases

NCT02422875 2025-09-30

Comparative Autoantibody and Immunologic Cell Marker Study

Enrolling by invitation

2,500 enrolled

Undifferentiated Connective Tissue Diseases, Immunoglobulin G4-Related Disease, Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, Autoimmune Diseases, Communicable Diseases, Graft vs Host Disease, Hepatitis C, Lupus Erythematosus, Systemic, Myositis, Sjogren's Syndrome, Purpura, Thrombocytopenic, Idiopathic, Sepsis, Epstein-Barr Virus Infections, Guillain-Barre Syndrome, Scleroderma, Diffuse, Autoimmune Lymphoproliferative Syndrome

NCT04525833 2025-09-19

Liver Disease and Other Systemic Diseases

Recruiting

15,000 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Diseases, Disease Progression, Carcinogenesis, Non-alcoholic Fatty Liver Disease

NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Phase 2 Completed

15 enrolled 8 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT07038863 2025-06-26

Mondelta

Phase NA Not yet recruiting

2,000 enrolled

Gastrointestinal

Hepatitis D, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT03534141 2025-05-16

MHALT

Phase NA Terminated

175 enrolled 19 charts

GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

Clinical Trials

Mammo'C

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Comparative Autoantibody and Immunologic Cell Marker Study

Liver Disease and Other Systemic Diseases

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Mondelta

MHALT

Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation

MATCHES

VERYMARKERS

CLOVER

Utilization of MAsS in Patients Undergoing LT for HCC

Ablation of Hepatocellular Carcinoma: a Nationwide Study

Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population

Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy

RCT

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers

ECHAPS

Possible Differences in HCC Course Depending on DAA Treatment

Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

Effect of DAAs on Behavior of HCC in HCV Patients

Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening

STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention

HEPCASUS

Association of Hepatitis C Virus With Breast Cancer

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

STOP-HCC

Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma

A2ALL-2

Optimal

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

A2ALL-1

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

RECAR

OPTISCREEN-III

Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

ROLFH

Association Between Hepatitis C Infection and Renal Cell Carcinoma

Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.

Genetic Analysis of Liver Cancer

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

PICTURE

Sonazoid Enhanced Liver Cancer Trial for Early Detection

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis